Cure Announces AI-Focused Session for Biotechnology International Convention in Boston
The session will focus on leveraging AI for good.
Cure®, a healthcare innovation campus in New York City, announced a one-of-a-kind session featuring experts focused on leveraging AI for good as part of the company's presence at the Biotechnology International Convention, the largest global event for the biotech industry, in Boston, MA. from June 5 to 8, 2023.
"The dizzying array of things AI can seemingly do–good, great, and worrisome–has the world of healthcare both excited and overwhelmed. For the BIO Super Session, the panel Cure has gathered will discuss how we can optimally leverage AI and other advanced technologies while mitigating risks," said Cure Chief Executive Officer Seema Kumar. "We also will challenge emerging digital entrepreneurs to demonstrate how AI can take on truly tough challenges in healthcare, like predicting Alzheimer's Disease, providing early warnings for pandemics, or curing cancer."
Continue reading this story here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
